Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  zidovudine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 35 for your search:
Start Over
Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial of Two Dose Levels of AZT in the Treatment of Human Immunodeficiency Virus Infection in Patients with AIDS-Associated Kaposi's Sarcoma
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NIAID
Protocol IDs: NIAID-ATEU-001, NCI-V86-0151
Phase I/II Evaluation of DM/MTX/CF plus Cranial Irradiation plus AZT for AIDS-Related Primary CNS Lymphoma
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 to 70
Sponsor: NIAID
Protocol IDs: NIAID-ATEU-009, NCI-V87-0223
Phase I/II Trial of AZT/IFN-alpha in AIDS Patients with Kaposi's Sarcoma
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 to 60
Sponsor: NIAID
Protocol IDs: NIAID-87-I-32, NCI-V87-0232
Phase I/II Study of FLAP (5-FU/LV/AZT/DP) in Patients with Metastatic Colorectal Adenocarcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8916C, NCI-90-C-45C, NCI-T89-0135N, T89-0135
Phase I/II Pilot Study of Cytotoxic Chemotherapy with CTX/DOX/VP-16/VCR/MTX/CF plus Recombinant GM-CSF, AZT, and Inhaled Pentamidine in Patients with AIDS-Associated non-Hodgkin's Lymphoma (Summary Last Modified 06/90)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-90-C-34, NCI-MB-249, NCI-T89-0194N, T89-0194
Phase I/II Study of CTX/VCR/DOX/VP-16 with ddI, G-CSF, and CNS Prophylaxis/Therapy in Patients with AIDS-Associated non-Hodgkin's Lymphoma (Summary Last Modified 07/92)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-92-C-0162, NCI-T92-0039N, T92-0039
Phase II Study of ZDV/IFN-A in Patients with HTLV-I-Associated Adult T-Cell Leukemia/Lymphoma (Summary Last Modified 06/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-94-C-0070F, NCI-T93-0149N, T93-0149
Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068204, AMC-019, NCT00006264
Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069469, U01CA070019, AMC-033, NCT00041327
Phase II Study of ADR/CTX/BLEO/VCR/DM/MTX/CF plus AZT with or without Cranial Radiotherapy for AIDS-Related High-Grade Lymphoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: over 18 and under 70
Sponsor: NIAID
Protocol IDs: NIAID-ATEU-008, NCI-V87-0217
Phase II Study of ZDV and IFN alpha-2a in Patients with AIDS-Associated Kaposi's Sarcoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 12 and over
Sponsor: NIAID
Protocol IDs: NIAID-ACTG-096, NCI-V89-0286
Phase II Pilot Study of TRA and Antiretroviral Therapy in HIV-Related Kaposi's Sarcoma (Summary Last Modified 02/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18 to less than 70
Sponsor: NCI
Protocol IDs: LAC-USC-17K911, NCI-T91-0126D, T91-0126
Phase II Study of Intermittent, High-Dose ZDV and 5-FU/CF in Patients with Metastatic Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NEDH-91062184, NCI-V92-0003
Phase II Study of Weekly Oral MTX/ZDV in Patients with Unresectable or Metastatic Adenocarcinoma of the Pancreas or Hepatoma (Summary Last Modified 06/93)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: HOG-GI91-1, NCI-V92-0196
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: DM93-058, P30CA016672, MDA-DM-93058, NCI-T93-0088D, CDR0000078316, T93-0088, NCT00002524
Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000441214, NCI-05-C-0203, NCI-P6330, NCT00217503
Phase I Pilot Study of ZDV in HIV-Seropositive Patients Undergoing Allogeneic Bone Marrow Transplantation for non-Hodgkin's Lymphoma (Summary Last Modified 03/95)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 12 and over
Sponsor:
Protocol IDs: FHCRC-526.0, NCI-V94-0412
Start Over